ArticleInternational urology and nephrology2026
Development of a nomogram for prediction of postoperative bleeding after transurethral resection of bladder tumors.
Article in International urology and nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePostoperative bleeding is a known complication following transurethral resection of bladder tumors (TURBT). Although factors like tumor size and anticoagulant use are associated with increased bleeding risk, no validated prediction tool currently exists. This study aimed to determine predictors and develop a clinical tool for preoperative bleeding risk assessment.
methodsWe conducted a retrospective analysis of patients undergoing TURBT at the University Hospital of Zurich between January 2016 and November 2022. Bleeding events were defined by four criteria: hemoglobin drop of ≥ 4 g/dl, need for transfusion, gross hematuria requiring prolonged irrigation, or surgical revision for bleeding during hospitalization or within 2 weeks after dischargement.
resultsDuring this time period, 447 TURBTs were performed, of which 54 (12.1%) were associated with a bleeding event. Univariable logistic regression identified five significant predictors (p value < 0.05): HAS-BLED score, high-risk alcohol consumption, use of oral anticoagulant and/or platelet aggregation inhibitors, and bridging therapy. In the multivariable logistic regression model, only high-risk alcohol consumption and platelet aggregation inhibitors remained statistically significant (p value < 0.05). All predictors had positive coefficients, indicating increased bleeding risk. A nomogram was developed based on these variables to assist in preoperative risk assessment. The model showed good calibration (Brier score = 0.097) and strong overall fit (Likelihood Ratio Test: χ
conclusionWe developed a predictive model for bleeding risk after TURBT. This tool may support perioperative management, by raising awareness of risk factors for bleeding complications and enabling tailored interventions for at-risk patients.
Indexed as
Identifiers
40892146What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.